Skip to main content
. 2023 Aug 7;10(5):3019–3027. doi: 10.1002/ehf2.14459

Figure 1.

Figure 1

Prevalence of class I recommendations over time. AF, atrial fibrillation; CVP, cardiovascular prevention; HF, heart failure; n, number of class I recommendations over total recommendations in each guideline document; NSTEMI, non‐ST elevation myocardial infarction; PE, pulmonary embolism; VHD, valvular heart disease.